Sean D. Rodgers, P.C.

Since joining Kirkland, Sean's representative transactions have included:

• Butterfly Equity in its $510 million acquisition of Bolthouse Farms from Campbell Soup Company

• Staples Inc. in its $996 million acquisition of Essendant Inc.

• GTCR and Sycamore Partners in the $1.1 billion acquisition of CommerceHub, Inc.

• Sycamore Partners in its $6.9 billion acquisition of Staples, Inc.

• Butterfly Enterprises in its equity investment in Lemonade Restaurant Group

• Cinven in its acquisition of Bioclinica

• KKR in its acquisition of Optiv Security

• KKR in its investment in UFC

• Silver Lake Partners in its acquisition of CAPS Payroll

• Silver Lake Partners in its acquisition of Final Draft

• Bristol-Myers Squibb in its up to $3 billion divestiture of its HIV pipeline to ViiV Healthcare

• Sycamore Partners in its $3 billion acquisition of Belk

• Boehringer Ingelheim in its $2.7 billion sale of Roxane Laboratories, Boehringer’s U.S. specialty generic drugs business, to Hikma Pharmaceuticals

• Building Materials Holding Corporation in its $1.5 billion all-stock merger with Stock Building Supply Holdings, Inc.

• Silver Lake Partners in its $700 million acquisition of Cast & Crew Entertainment Services

• Rede D’Or São Luiz S.A. in its $600 million equity sale to The Carlyle Group

• Bristol-Myers Squibb in its sale of the North American commercialization rights Erbitux to Eli Lilly

• Climatec in its sale to Robert Bosch North America Corporation

• KKR in its acquisition of C.H.I. Overhead Doors

• KKR in its acquisition, along with Anchor Equity Partners and Ticket Monster management, of a controlling interest in Ticket Monster from Groupon in a transaction based on a fully diluted valuation of $782 million

• London Stock Exchange Group plc in its $2.7 billion acquisition of the entire issued share capital of Frank Russell Company

• Siris Capital Group in its $250 million acquisition of the Pulse product portfolio of Juniper Networks

• Bristol-Myers Squibb in its $4.3 billion sale of its diabetes alliance to AstraZeneca

Prior to joining Kirkland, Sean’s representative transactions included:

• KKR in its $3.9 billion acquisition of Gardner Denver Inc.

• KKR in its $150 million investment in Sentio Healthcare Properties, Inc.

• KKR in its acquisition of PRA Holdings

• KKR in its acquisition of ReSearch Pharmaceutical, Inc.

• KKR in its acquisition of Mitchell International

• Capsugel in its acquisition of Bend Research

• Sageview Capital in its $38 million investment in United Capital

• Sealy Corporation in its $1.3 billion sale to Tempur-Pedic International

• Cadence Bancorp in its $250 million acquisition of Encore Bancshares, Inc.

• Sageview Capital in its $100 million investment in Everbank

• Sealy Corporation in its joint venture with Comfort Revolution

• KKR in its $2.4 billion acquisition of Capsugel from Pfizer

• KKR in its $425 million acquisition of Ipreo

• Angelo Gordon in its acquisition of C&D Technologies

• CoStar in its $860 million acquisition of LoopNet

• Pola Orbis in its $300 million acquisition of Jurlique International

• Investor Group in its $1 billion acquisition for 25% of Santander Consumer USA Inc.

• KKR Capital Markets in its $235 million debt refinancing for Harden Healthcare

• Special Committee of Mediacom in its $3.6 billion buy-out by founding shareholder

• United States Treasury in its $700 billion equity structuring of the TARP Program

• Special Committee of Hearst-Argyle Television, Inc. in the sale to Hearst Corp.

• Corsair Capital in its $7 billion capital raising for National City Corp.

• KKR in its $29 billion acquisition of First Data

• Sageview Capital and KKR in its $975 million acquisition of ACTS LP Assets

• NXP Semiconductors in its $285 million acquisition of the cellular communications business of Silicon Laboratories Inc.

• Evenflo in its sale to Harvest Partners

• KKR in its $21.3 billion acquisition of HCA, Inc.

• KKR in its $1.4 billion acquisition of Cleanaway and Brambles Industrial Services

• KKR in its $900 million acquisition of Aricent from Flextronics

• Ford Motor Co. in its $5.6 billion sale of The Hertz Corp.

• Seagate in its $1.9 billion acquisition of Maxtor

• KKR in its $1.3 billion acquisition of Accellent Inc.

• Borden Chemical in its $1.2 billion sale to Apollo

• Wyeth as the controlling shareholder of Immunex in its $16 billion sale to Amgen